The Aplastic Anemia market presents opportunities in novel therapies, with 5+ companies and 8+ drugs in various development stages. Key focus is on innovative treatment approaches, partnerships, and ...

Anemia of chronic disease is anemia caused by inflammation from a long-term or chronic illness. It is also called anemia of inflammation. People with anemia of chronic disease may have normal or even ...

By Shreoshree Chakrabarty Autoimmune Hemolytic Anemia (AIHA) is a rare but serious type of anemia in which the immune system ...

Childhood anemia is a condition where there is a low number of red blood cells. Symptoms can include pale skin, low energy, and breathlessness. Treatments may include supplements, dietary changes, and ...

Anemia affects almost 1 in 4 people worldwide. But while billions of people live with the disease, its signs and symptoms aren’t just part of everyday life. “Anemia is one of the most common global ...

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Anemia Treatment Market Report by Disease Type, Therapy Class, Route of Administration, Countries and Company Analysis, 2025-2033" report has been added ...

Sotagliflozin, a dual sodium-glucose cotransporter 1 and 2 inhibitor, rapidly improves hemoglobin levels in patients with type 2 diabetes (T2D) and moderate to severe chronic kidney disease (CKD), ...